Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gone therapy and magnetic antibody cell separation

Clinical Cancer Research

Volumn 5, Issue 6, 1999, Pages 1557-1568

  Marini, Frank C ^a   Snell, Virginia ^a   Yu, Qingnan ^a   Zhang, Xin ^a   Singletary, S Eva ^a   Champlin, Richard ^a   Andreeff, Michael ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ARTICLE; BONE MARROW BIOPSY; BONE MARROW PURGING; BREAST CANCER; CANCER CELL DESTRUCTION; CELL ISOLATION; CONTAMINATION; CONTROLLED STUDY; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

ADENOVIRIDAE; BREAST NEOPLASMS; CELL SURVIVAL; COCULTURE TECHNIQUES; COLONY-FORMING UNITS ASSAY; FEMALE; GANCICLOVIR; GENE EXPRESSION; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOMAGNETIC SEPARATION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033011773     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ross, A. A., Cooper, B. W., Lazarus, H. M., Mackay, W., Moss, T. J., Ciobanu, N., Tallman, M. S., Kennedy, M. J., Davidson, N. E., and Sweet, D. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood, 82: 1205-1210, 1993.
2. Cote, R. J., Rosen, P. P., Lesser, M. L., Old, L. J., and Osborne, M. P. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J. Clin. Oncol., 9: 1749-1756, 1993.
3. Gee, A., Purging of peripheral blood stem cells grafts. Stem Cells, 13 (Suppl.): 141-148, 1995.
4. Gribben, J. G., Arnold, M. D., Freedman, M. D., Neuberg, D., Roy, D. C., Blake, K., Woo, S. D., Grossbard, M. L., Rabinowe, S. N., Coral, F., Freedman, G. J., Ritz, J., and Nadler, L. M. Immunologic purging of marrow assessed before autologous bone marrow transplantation for B-cell lymphoma. N. Engl. J. Med., 325: 1525-1533, 1991.
5. Schpall, E. J., Jones, R. B., Bast, R. C., Rosner. G. L., Vandermark, R., Ross, M., Affronti, M. L., Johnston, C., Eggleston, S., and Tepperburg, M. 4-Hydroperoxy-cyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a Phase I trial. J. Clin. Oncol., 9: 85-93, 1991.
6. Kies, M. S., Gordon, L. I., Rosen, S. T., Kucuk, O., and Vriesendorf, H. M. Autologous bone marrow transplantation in breast cancer: separation of clonogenic tumor cell colonies by gradient fractionation. Exp. Hemtol., 16: 190-194, 1988.
7. Meyers, B. F., Stoner, M. L., Rapheal, C. L., Davis, R. E., and Hermann, R. P. Strepavidin-biotin immunotoxin: a new approach to purging bone marrow. Exp. Hematol., 19: 710-713, 1991.
8. Simpson, S. J., Vachula, M., Kennedy, M. J., Kaizer, H., Coon, J. S., Ghalie, R., Williams, S., and Van Epps, D. Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry. Exp. Hematol., 23: 1062-1068, 1995.
9. Gross, H-J., Verwer, B., Houck, D., Hoffman, R. A., and Reckentwald, D. Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10-7. Proc. Natl. Acad. Sci. USA, 92: 537-541, 1995.
10. Stratford-Perricaudet, L. D., Leverro, M., Chasse, J., Perricaudet, M, and Briand, P., Evaluation of the transfer and expression in mice of an enzyme-encoding gene using an adenovirus vector. Hum. Gene Ther., 1: 246-256, 1990.
11. Smythe, W. R., Hwang, H. C., Knjlata, M. A., Eck, S. L., Davidson, B. L., Wilson, J. M., Kaiser, L. R., and Albelda, S. M. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSV tk) gene to thoracic neoplasm: an effective in vitro drug sensitization system. Cancer Res., 54: 2055-2059, 1994.
12. Brody, S. L., Jaffe, H. A., Han, S. K., Wersto, R. P., and Crystal R. G., Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors. Hum. Gene Ther., 5: 437-447, 1994.
13. Liu, J., El-Maggar, A., McDonnell, T., Steck, K., Wang, M., Taylor, D., and Clayman, G. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res., 55: 3117-3122, 1995.
14. Chen, S-H., Shine, D., Goodman, R. G., and Woo, S. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vitro. Proc. Natl. Acad. Sci. USA, 91: 3054-3057, 1994.
15. Brody, S., Metzger, M., Danel, C., Rosenfeld, M. A., and Crystal, R. Acute response of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther., 5: 821-836, 1994.
16. Marini, F. C., Cannon, J., Belmont, J., Shillitoe, E. J., and Lapeyre, J. N. In vivo marking of spontaneous or vaccine induced fibrosarcomas in domestic house cat, using a adenoviral vector containing a bifunctional fusion protein GAL-TEK. Hum. Gene Ther., 6: 1215-1223, 1995.
17. Moolten, F. L. Tumor chemosensitivity by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res., 46: 5276-5281, 1986.
18. Cheng, Y. C., Grill, S. P., Dutschman, G. E., Nakayma, K., and Bastow, K. F. Metabolism of 9-(1,3 dihydroxy-2-prooxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells. J. Biol. Chem., 258: 12460-12464, 1983.
19. Faulds, D., and Heel, R. C. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infection. Drugs, 39: 597-638, 1990.
20. Wattel, E., Vanrumbeke, M., Abina, M. A., Cambier, N., Preudomme, C., Haddada, H., and Fenaux, P. Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies. Leukemia (Baltimore), 10: 171-174, 1996.
21. Seth, P., Brinkmann, N., Schwartz, G., Katayse, D., Gress, R., Pastan, I., and Crown, K. Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging. Cancer Res., 56: 1346-1351, 1996.
22. Marini, F. C., Zhang, X., Trapnell, B., and Andreeff, M. A. Bone marrow purging of residual breast cancer cells by adenoviral transfer of the HSV-tk gene. Blood, 88 (Suppl.): 1076, 1996.
23. Chen, L., Pulsipher, M., Chen, D., Sieff, C., Elias, H., Fine, H., and Kufe, D., Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J. Clin. Invest., 98: 2539-2548, 1996.
24. Wroblewski, J., Lay, L., Van Zant, G., Phillips, G., Seth, P., Curiel, D., and Meeker, T. Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cells autographs using recombinant adenovirus. Cancer Gene Ther., 3: 257-264, 1996.
25. Miltenyi, S., Muller, W., Weichel, W., and Radbruch, A. High gradient magnetic separation with magnetic cell separation (MACS). Cytometry, 11: 231-234, 1990.
26. Hildebrandt, M., Mapara, M. Y., Korner, I. J., Bargou, R. C., Moldenhauer, G., and Dorken, B., Reverse transcriptase-polymerase chain reaction-controlled immunomagnetic purging of breast cancer using the magnetic cell separation (MACS) system: a sensitive method for monitoring purging efficiency. Exp. Hematol., 25: 57-65, 1997.
27. Rosenfeld, M. A., Yoshimura, K., Trapnell, B. C., Yoneyama, K., Fukayama, M., Steir, L. R., Paakko, P. K., Gilardi, P., Stratford-Perricaudet, L. D., Perricaudet, M., Guggino, W. B., Pavirani, A., Lecocq J-P., and Crystal, R. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell, 68: 143-155, 1992.
28. Van Ginkel, F. W., Liu, C., Simecka, J. W., Dong, J-Y., Greenway, T., Frizzell, R. A., Kiyono, H., McGhee, J. R., and Pascual, D. W. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase. Hum. Gene Ther., 6: 895-903, 1995.
29. Clarke, M. F., Apel, I. J., Benedict, M. A., Eipers, P. G., Sumantran, V., Gonzalez-Garcia, M., Doedens, M., Fukunaga, N., Davidson, B., Dick, J. E., Minn, A. J., Boise, L. H., Thompson, C. B., Wicha, M., and Nunez, G. A recombinant BCL-X adenovirus selectively induces apoptosis in cancer cells but not normal marrow cells. Proc. Natl. Acad. Sci. USA, 92: 11024-11028, 1995.
30. +) using CMV driven adenoviral vectors (ad-v). Blood, 88 (Suppl.): 3896, 1996.
31. Brenner, M. K., Rill, D. R., Moen, R. C., Krance, R. A., Mirro, J., Anderson, W. F., and Ihle, J. N. Gene-marking to trace origin of relapse after autologous bone marrow transplant. Lancet, 341: 85-89, 1993.
32. Deissorth, A., Zu, Z., and Claxton, D. Genetic marking shows that Ph+ cells present in autologous transplant of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood, 83: 3068-3076, 1994.
33. Sharp, J. G., Kessinger, A., and Vaughn, W. P. Detection and clinical significance of minimal tumor cell contamination of peripheral stem cell harvests. Int. J. Cell Cloning, 10: 92-97, 1992.
34. Fields, K. K., Elfenbein, G. J., Trudeau, W. L., Perkins, J. B., Janssen, W. E., and Moscinski, L. C. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J. Clin. Oncol., 14: 1868-1876, 1996.
35. Gasparini, G., Brooks, P. C., Biganzoli, E., Vermeulen, P. B., Bonoldi, E., Dirix, L. Y., Ranieri, G., Miceli, R., Cheresh, D. A., Vascular integrin alpha (v)beta3: a new prognostic indicator in breast cancer. Clin. Cancer Res., 4: 2625-2634, 1998.
36. Bergelson, J. M., Cunningham, J. A., Droguett, G., and Kurt-Jones, E. A. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science (Washington DC), 275: 1320-1323, 1997.
37. Huang, M. R., Olsson, M., Kallin, A., Pettersson, U., and Totterman, T. H. Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cells. Gene Ther., 4: 1093-1099, 1997.
38. Watanabe, T., Kusynski, C., Ino, K., Heimann, D. G., Shepard, H. M., Yasui, Y., Maneval, D. C., and Talamadge, J. E. Gene transfer into human marrow hematopoietic cells mediated by adenoviral vectors. Blood, 87: 5032-5039, 1996.
39. Frey, B. M., Hackett, N. R., Bergelson, J. M., Finberg, R., Crystal, R. G., Moore, M. A., Rafii, S., High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors. Blood, 91: 2781-2792, 1998.
40. Kim, M., Wright, M., Deshane, J., Accavitti, M. A., Tilden, A., Saleh, M., Vaughan, W. P., Carabasi, M. H., Rogers, M. D., Hockett, R. D., Grizzle, W. E., and Curiel, D. T. A novel gene therapy strategy for the elimination of prostate carcinoma cells from human bone marrow. Hum. Gene Ther., 8: 157-170, 1997.
41. Wilson, J. When bad gene transfer is good. J. Clin. Invest., 98: 2435, 1996.
42. Garcia-Sanchez, F., Fu, S. Q., Nanakorn, T., Krause, D. S., Liang, J., Adams, E., Leffert, J. J., Yin, L. H., Cooperberg, M. R., Hanania, E., Wang, W. L., Won, J. H., Peng, X. Y., Cote, R., Brown, R., Burtness, B., Giles, R., Crystal, R., and Deisseroth, A. B. Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation. Blood, 92: 672-682, 1998.